Antibody-conjugated liposomes targeting NF-κB may enhance antitumor effects against tumor cells by improving cell-specific binding and internalization, potentially leading to the destruction of T cell lines. This approach may be applicable for the treatment targeting tumor cells, but specific mechanisms and effects require further research support.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1711MZ | Recombinant Mouse Anti-Human NFKB1 Antibody | IHC-P, WB | Mouse antibody |
MRO-1091-CN | Recombinant Rabbit Anti-NFKB1 Monoclonal Antibody (CBACN-400) | WB, IHC | Rabbit IgG |
VS3-QX809 | Mouse Anti-NFKB1 Recombinant Antibody (clone 5E3-E4-C11) | WB | Mouse IgG1 |
VS3-QX810 | Mouse Anti-NFKB1 Recombinant Antibody (clone 1298CT792.105.117.133) | WB, IHC, FC | Mouse IgG1, κ |
VS3-CJ754 | Rabbit Anti-NFKB1 Recombinant Antibody (VS3-CJ754) | WB, IHC | Rabbit IgG |
There are currently no Customer reviews or questions for VS-1024-FY22. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.